In summary, our findings indicate that the Alzheimer’s disease-associated Trem2 R47H variant confers a loss of TREM2 function, impairing myeloid cell responses to pathology. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.